Prof. Jayanta Chatterjee is a Consultant Gynae-oncologist at
the Royal Surrey Foundation Trust Hospital (Guildford) associated with the
renowned St Luke's Cancer Centre. He is a sub-specialist in Gynae-oncology
surgery, having done his fellowship at the prestigious West London
Gynae-oncology Cancer Center at the Hammersmith Hospital in London. He is an
honorary Professor at the Brunel Medical School, College of Health, Medicine
and Life Sciences at Brunel University, London. His primary research interest
is in translational research, aimed at promoting new biomarker discovery and
validation in gynecological cancers. He has published on clinical interventions
improving patient outcomes from gynecological cancers. He is also part of the
team involved in research in Human Uterine transplants in the UK. He is
presently working to develop genomic, proteomic, and immunomic characterization
of tumors so that novel therapies can be applied to personalized cancer care to
improve survival from gynecological cancers. He is also an honorary Clinical
Senior Lecturer at Imperial College, London where he did his doctoral research
looking at a novel immune pathway in ovarian cancer. He is internationally
known for his surgical expertise in advanced open abdominal, laparoscopic, and
robotic surgical skills. He was also a council member of the Royal College of
Obstetricians and Gynaecologists and sat on numerous educational committees.
Prof. Jayanta Chatterjee is a Consultant Gynae-oncologist at
the Royal Surrey Foundation Trust Hospital (Guildford) associated with the
renowned St Luke's Cancer Centre. He is a sub-specialist in Gynae-oncology
surgery, having done his fellowship at the prestigious West London
Gynae-oncology Cancer Center at the Hammersmith Hospital in London. He is an
honorary Professor at the Brunel Medical School, College of Health, Medicine
and Life Sciences at Brunel University, London. His primary research interest
is in translational research, aimed at promoting new biomarker discovery and
validation in gynecological cancers. He has published on clinical interventions
improving patient outcomes from gynecological cancers. He is also part of the
team involved in research in Human Uterine transplants in the UK. He is
presently working to develop genomic, proteomic, and immunomic characterization
of tumors so that novel therapies can be applied to personalized cancer care to
improve survival from gynecological cancers. He is also an honorary Clinical
Senior Lecturer at Imperial College, London where he did his doctoral research
looking at a novel immune pathway in ovarian cancer. He is internationally
known for his surgical expertise in advanced open abdominal, laparoscopic, and
robotic surgical skills. He was also a council member of the Royal College of
Obstetricians and Gynaecologists and sat on numerous educational committees.